Annual Drug Patent Expirations for OZURDEX
Ozurdex is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are seven patents protecting this drug.
This drug has one hundred and ten patent family members in twenty-eight countries.
The generic ingredient in OZURDEX is dexamethasone. One supplier is listed for this compound. Additional details are available on the dexamethasone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
